Medcan Australia is
pleased to announce its first shipment of imported Medicinal Cannabis products
have been received.
The receipt of these Medcan branded products validates Medcan’s supply chain and confirms Medcan’s ability to navigate the import/export process for Medicinal cannabis products.
Successful importation of Medcan’s first branded products allows:
1. the supply of branded products into Medcan’s Australian Doctor/Pharmacist networks
2. the supply of branded products into Medcan’s clinical trials
3. the ability to commence stability trials
4. an immediate additional revenue stream to support Medcan’s business development"
Craig Cochran, Managing Director, Medcan Group Pty Ltd, 11 November 2019.
Please read the full announcement via the link below.
For more information about Medcan please click here.